The cognitive aging field has long debated whether presymptomatic brain disease accounts for a proportion of what is considered to be normal age-related cognitive decline. This is most notable in relation to Alzheimer's disease (AD) not only because it is a highly prevalent age-associated condition, but also because several features of AD are seen in normal aging. In particular, decline in episodic memory, deposition of ?- amyloid plaques, and neurofibrillary tangle-related hippocampal atrophy are all aspects of AD that are also common in cognitively intact older people. However, the effects of AD pathology are not straightforward and are likely to be mediated by intervening factors that can be characterized as vulnerability and reserve. Within the past several years, scientific advances have allowed the measurement of the multiple processes that may be involved in this model of age-related memory loss. Thus, it is possible to measure ?-amyloid with positron emission tomography (PET) and the amyloid imaging agent [11C] Pittsburgh Compound B (PIB), to assess neurofibrillary tangle burden and hippocampal atrophy with magnetic resonance imaging (MRI), and to assess reserve processes with PET measures of glucose metabolism (using [18F]-Flurodeoxyglucose, or FDG) and with functional MRI (fMRI). In this project, a group of 125 older cognitively intact individuals will be recruited over 5 years, carefully characterized in terms of overall cognition and episodic memory, and studied with PIB- and FDG-PET imaging and structural MRI. A subgroup of 50 of these subjects, along with 50 healthy young subjects will be studied with fMRI and an event-related behavioral paradigm that contrasts brain activity during successfully remembered and forgotten items. A major question is whether, and how, older people without evidence of ?- amyloid deposition or hippocampal atrophy differ from older people with these characteristics, and from younger people. In addition key hypotheses will be tested in continuous multivariate models in which PET measures of ?-amyloid and MR measures of hippocampal atrophy are expected to be related to poorer episodic memory function, while resting prefrontal glucose metabolism will attenuate this relationship. Similar findings are expected during cognitive activity using fMRI, in which diminished brain activity in the medial temporal lobes may be related to ?-amyloid deposition, and better performance may be related to increased prefrontal cortical activation. Finally, a subgroup of subjects will be re-evaluated at a 2-year interval to see whether these measures predict change over time in cognition. In total, this project will both provide a description of optimal cognitive aging independent of brain amyloid deposition, and will begin to unravel the mechanisms associated with the loss and preservation of memory function in aging.

Public Health Relevance

This project will assess whether and how Alzheimer's disease may account for the memory loss experienced by healthy normal older people. This is important both for understanding relationships between AD and normal aging, and for developing ways of optimizing brain function in aging.

National Institute of Health (NIH)
National Institute on Aging (NIA)
Research Project (R01)
Project #
Application #
Study Section
Special Emphasis Panel (ZAG1-ZIJ-5 (M2))
Program Officer
Wagster, Molly V
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Lawrence Berkeley National Laboratory
Organized Research Units
United States
Zip Code
Leal, Stephanie L; Landau, Susan M; Bell, Rachel K et al. (2017) Hippocampal activation is associated with longitudinal amyloid accumulation and cognitive decline. Elife 6:
Mander, Bryce A; Zhu, Alyssa H; Lindquist, John R et al. (2017) White Matter Structure in Older Adults Moderates the Benefit of Sleep Spindles on Motor Memory Consolidation. J Neurosci 37:11675-11687
Lockhart, Samuel N; Schöll, Michael; Baker, Suzanne L et al. (2017) Amyloid and tau PET demonstrate region-specific associations in normal older people. Neuroimage 150:191-199
Lockhart, Samuel N; Ayakta, Nagehan; Winer, Joseph R et al. (2017) Elevated 18F-AV-1451 PET tracer uptake detected in incidental imaging findings. Neurology 88:1095-1097
Baker, Suzanne L; Maass, Anne; Jagust, William J (2017) Considerations and code for partial volume correcting [18F]-AV-1451 tau PET data. Data Brief 15:648-657
Marks, Shawn M; Lockhart, Samuel N; Baker, Suzanne L et al. (2017) Tau and ?-Amyloid Are Associated with Medial Temporal Lobe Structure, Function, and Memory Encoding in Normal Aging. J Neurosci 37:3192-3201
Baker, Suzanne L; Lockhart, Samuel N; Price, Julie C et al. (2017) Reference Tissue-Based Kinetic Evaluation of 18F-AV-1451 for Tau Imaging. J Nucl Med 58:332-338
Jagust, William (2016) Is amyloid-? harmful to the brain? Insights from human imaging studies. Brain 139:23-30
Mander, Bryce A; Winer, Joseph R; Jagust, William J et al. (2016) Sleep: A Novel Mechanistic Pathway, Biomarker, and Treatment Target in the Pathology of Alzheimer's Disease? Trends Neurosci 39:552-66
Schöll, Michael; Lockhart, Samuel N; Schonhaut, Daniel R et al. (2016) PET Imaging of Tau Deposition in the Aging Human Brain. Neuron 89:971-982

Showing the most recent 10 out of 54 publications